Complex spine disorder implant-maker Curiteva sold $8 million in equity to 16 investors Nov. 18, Mass Device reports.
What you should know:
1. Curiteva will use $2.2 million to pay off promissory notes and liquidation preferences. The company did not elaborate on what it would use the remaining funds for.
2. Curiteva developed the Sage cervical interbody fusion system and the Aptitude cervical plates.
3. The company is attempting to raise $20 million through the offering.